Table 1.
Summary of Literature Studies on the Predictive Value of Extracellular AUC for the Survival of Human Cancer Cell Lines After Exposure to Cisplatin.
Source | Cell/tumor type | AUC predicted cell survival? |
Range of exposure times (hours) | Replot needed* |
Troger et al. [2] | Head and neck cancer | No | 1–121 | No |
Nozue et al. [10] | Human gastric cancer | No | 1–72 | Yes |
Matsushima et al. [33] | Human lung carcinoma PC-7 | No | 1–24 | Yes |
Levasseur et al. [11] | Human ovarian and colon carcinomas | Yes | 1–24 | Yes |
Rupniak et al. [34] | Human ovarian carcinoma | Maybe | 1–18 | Yes |
Ma et al. [12] | IGROV1 ovarian | Yes | 1–20 | Yes |
Kurihara et al. [3] | Human gastric carcinoma | No | 1–25 | Yes |
Los et al. [35] | CC531 (colon carcinoma) | No | 1–4 | Yes |
Erlichman et al. [13] | MGH-U1 human bladder cancer | No | 1.3–4.4 | No |
Data are plotted versus extracellular concentration in the cited study.